Format: Download Video of Presenter plus Slides with Synchronized Audio

Presenter: Martin Gallagher, MD, DC

Chronic inflammation is considered, by most of the leading medical researchers, to be the underlying cause of chronic pain, musculoskeletal degeneration, and accelerated aging. Various forms of Regenerative Medicine, including Prolotherapy, PRP, Stem Cell Injections, Graston, acupuncture, chiropractic, etc. form the center piece of reversing chronic pain and inflammation with mechanical methods, such as injections of platelets and stem cells, manipulation, myofascial release, etc. Regeneration is dependent upon the down regulation of the inflammatory markers, and the activation of healthy, viable stem cells, particularly mesenchymal cells.

Seminal research indicates that specific nutraceuticals help to down-regulate the inflammatory response and promote musculoskeletal regeneration. In this presentation, I will explain how nutrients such as boswellia, methylated resveratrol, antioxidants, and a new ingredient solubilized keratin play a significant role in regenerative therapy by supporting healthy inflammation while stimulating new tissue growth. A specific boswellia extract providing AKBA has been clinically shown to target mediators of inflammation such as TNF-alpha, 5-lipoxygenase and MMP3. Clinical trials with a solublized keratin showed improvement in WOMAC pain scores. Researchers have reported vitamin D3, L-carnosine and antioxidant combinations produce a synergistic effect to promote proliferation of human stem cells.

Learning Objectives
Understand the role of inflammation and the key serum markers associated with chronic musculoskeletal pain.
-> Review the various regenerative medicine options, including prolotherapy and PRP.
-> Relate specific nutraceuticals to musculoskeletal regeneration and stem cell activation.
-> Learn the clinical application of new, combination nutraceuticals to specific conditions, such as chronic back pain, rotator cuff disorders, labral tears, chronic tendinopathies, etc.